Skip to main content
. 2024 Oct 8;15:20420188241277414. doi: 10.1177/20420188241277414

Table 5.

Correlations between salivary and serum levels of hormones for subgroups of patients with hypothyroidism, dependent on LT4 therapy.

LT4 therapy ECLIA-Cobas CLIA-LIAISON
fT4 [pmol/L]
R s p-Value R s p-Value
Salivary fT4 [pg/mL]
 Yes
N = 32
0.307 0.113 0.124 0.530
 No
N = 10
0.898 0.002 a 0.849 0.004 a
fT3 [pg/mL]
R s p-Value R s p-Value
Salivary fT3 [pg/mL]
 Yes
N = 32
0.271 0.163 0.156 0.429
 No
N = 10
0.898 0.002 a 0.728 a 0.026 a
a

p-value < 0.05.

TSH, thyroid stimulating hormone; fT4, thyroxine; fT3, tri-iodothyronine; LT4 levothyroxine; ECLIA-Cobas, electrochemiluminescence (ECLIA) immunoassays Elecsys® Cobas e801, Roche; CLIA-LIAISON, chemiluminescence immunoassay (CLIA) LIAISON XL®, DiaSorin; Rs, Spearman’s correlation coefficients.